tevogen.com (TVGN) - Long-Term Liabilities to Capital

This price action chart for Tevogen Bio Holdings (TVGN) demonstrates a metric of 0.00, which correlates with the potential for premium pricing power when bringing innovative T-cell therapies to market. The business focuses on developing immune solutions against oncology and viruses, enhancing the body's ability to combat pathologies. Furthermore, project development remains independent of economic cycles, although it is sensitive to borrowing costs.

For Tevogen Bio Holdings (TVGN), whose cell therapy developments remain independent of economic cycles, the share of long-term loans within the capital structure on GURU.Markets reflects the funding stability of its long-term programs. This ratio compares liabilities with a maturity of over one year against equity, allowing investors to assess financial leverage and the business's sensitivity to changes in market interest rates.